Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Neoplasms

Explore clinical trials studying Pancreatic Neoplasms. Study availability and eligibility vary by location and protocol.

2,460 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Neoplasms trial results

Completed

Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine

NCT00053222

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States
  • Evanston Northwestern Health Care - Evanston Hospital Evanston, Illinois, United States
  • Ingalls Memorial Hospital Harvey, Illinois, United States
View Trial Details
Completed

A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma

NCT01166490

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • TGen Clinical Research Service at Scottsdale Healthcare Scottsdale, Arizona, United States
  • University of California at San Francisco San Francisco, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT00425360

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • North Devon District Hospital Barnstaple, England, United Kingdom
  • Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom
  • Pilgrim Hospital Boston, England, United Kingdom
  • Royal Bournemouth Hospital Bournemouth, England, United Kingdom
View all 45 locations
View Trial Details
Completed

Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT00462852

Conditions
Cardiovascular Diseases, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations
  • Princess Royal Hospital at Hull and East Yorkshire NHS Trust Hull, England, United Kingdom
  • Royal Lancaster Infirmary Lancaster, England, United Kingdom
  • Saint Bartholomew's Hospital London, England, United Kingdom
  • St. George's Hospital London, England, United Kingdom
View Trial Details
Completed

Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery

NCT00335543

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Innsbruck Universitaetsklinik Innsbruck, Austria
  • Allgemeines Krankenhaus - Universitatskliniken Vienna, Austria
  • Robert Roessle Comprehensive Cancer Center - Charite Campus Buch Berlin, Germany
  • Knappschaft Krankenhaus Bochum, Germany
View all 17 locations
View Trial Details
Completed

3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

NCT00064051

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • Indiana Oncology Hematology Consultants Indianapolis, Indiana, United States
  • University of Minnesota Cancer Center Minneapolis, Minnesota, United States
  • Sarah Cannon Cancer Center at Centennial Medical Center Nashville, Tennessee, United States
View Trial Details

Related conditions